Daniel (Pete) Duncan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Deglutition Disorders | 10 | 2023 | 604 | 4.580 |
Why?
|
Gastroesophageal Reflux | 8 | 2023 | 782 | 3.300 |
Why?
|
Respiratory Aspiration | 4 | 2023 | 81 | 1.900 |
Why?
|
Deglutition | 3 | 2023 | 197 | 0.940 |
Why?
|
Bronchiectasis | 1 | 2022 | 128 | 0.800 |
Why?
|
Laryngomalacia | 1 | 2021 | 30 | 0.790 |
Why?
|
Anti-Ulcer Agents | 1 | 2021 | 119 | 0.750 |
Why?
|
Esophagitis, Peptic | 1 | 2021 | 77 | 0.740 |
Why?
|
Blood Vessel Prosthesis | 7 | 2015 | 933 | 0.720 |
Why?
|
Food Additives | 1 | 2019 | 19 | 0.700 |
Why?
|
Hospitalization | 6 | 2022 | 10232 | 0.670 |
Why?
|
Pneumonia, Aspiration | 1 | 2018 | 144 | 0.620 |
Why?
|
Nutritional Support | 1 | 2019 | 168 | 0.590 |
Why?
|
Child, Hospitalized | 1 | 2018 | 174 | 0.590 |
Why?
|
Laryngeal Diseases | 1 | 2019 | 241 | 0.530 |
Why?
|
Dioxoles | 1 | 2015 | 104 | 0.500 |
Why?
|
Proton Pump Inhibitors | 1 | 2018 | 521 | 0.460 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2015 | 314 | 0.460 |
Why?
|
Tissue Engineering | 6 | 2015 | 1877 | 0.450 |
Why?
|
Infant | 12 | 2023 | 35070 | 0.440 |
Why?
|
Fluoroscopy | 3 | 2023 | 924 | 0.410 |
Why?
|
Constriction, Pathologic | 2 | 2015 | 1095 | 0.410 |
Why?
|
Pneumonia | 1 | 2023 | 2117 | 0.410 |
Why?
|
Benzamides | 1 | 2015 | 1378 | 0.340 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 1 | 2006 | 61 | 0.270 |
Why?
|
Boston | 4 | 2019 | 9305 | 0.260 |
Why?
|
Pediatrics | 1 | 2019 | 3462 | 0.240 |
Why?
|
Retrospective Studies | 12 | 2023 | 77098 | 0.230 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7645 | 0.220 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7276 | 0.200 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.200 |
Why?
|
Family Health | 1 | 2006 | 1282 | 0.190 |
Why?
|
Muscle Proteins | 1 | 2006 | 1159 | 0.190 |
Why?
|
Vena Cava, Inferior | 3 | 2012 | 436 | 0.180 |
Why?
|
Glottis | 1 | 2021 | 217 | 0.180 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2021 | 134 | 0.170 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2021 | 169 | 0.170 |
Why?
|
Sarcoma | 2 | 2021 | 1895 | 0.170 |
Why?
|
Gene Rearrangement | 2 | 2021 | 1179 | 0.160 |
Why?
|
Risk Factors | 6 | 2022 | 72145 | 0.160 |
Why?
|
Hospitals, Pediatric | 2 | 2019 | 1760 | 0.160 |
Why?
|
Viscosity | 1 | 2019 | 328 | 0.160 |
Why?
|
Polyglycolic Acid | 3 | 2015 | 406 | 0.160 |
Why?
|
Gene Fusion | 1 | 2021 | 371 | 0.160 |
Why?
|
Janus Kinase 2 | 1 | 2021 | 527 | 0.160 |
Why?
|
Humans | 29 | 2023 | 742088 | 0.150 |
Why?
|
Gastroenterology | 1 | 2023 | 534 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 704 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2020 | 535 | 0.140 |
Why?
|
Child | 8 | 2023 | 77478 | 0.140 |
Why?
|
Prescriptions | 1 | 2019 | 387 | 0.140 |
Why?
|
Prospective Studies | 4 | 2023 | 53187 | 0.140 |
Why?
|
Tissue Scaffolds | 6 | 2012 | 957 | 0.130 |
Why?
|
Breast Feeding | 1 | 2023 | 1339 | 0.130 |
Why?
|
Blood Vessels | 2 | 2011 | 1124 | 0.120 |
Why?
|
Medicine | 1 | 2023 | 941 | 0.120 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2021 | 798 | 0.120 |
Why?
|
Guided Tissue Regeneration | 2 | 2011 | 85 | 0.120 |
Why?
|
Female | 16 | 2023 | 379592 | 0.110 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39004 | 0.100 |
Why?
|
Male | 13 | 2021 | 349538 | 0.100 |
Why?
|
Uterine Neoplasms | 1 | 2020 | 1513 | 0.090 |
Why?
|
Vascular Grafting | 1 | 2011 | 142 | 0.090 |
Why?
|
Child, Preschool | 4 | 2019 | 40955 | 0.090 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2012 | 233 | 0.090 |
Why?
|
Parents | 1 | 2023 | 3387 | 0.090 |
Why?
|
Carcinoma | 1 | 2021 | 2374 | 0.080 |
Why?
|
Treatment Outcome | 3 | 2021 | 62966 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 3020 | 0.080 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2021 | 2229 | 0.080 |
Why?
|
Cell Transplantation | 1 | 2010 | 477 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4553 | 0.070 |
Why?
|
Lung | 2 | 2023 | 9826 | 0.070 |
Why?
|
Societies, Medical | 1 | 2019 | 3740 | 0.070 |
Why?
|
Macrophages | 2 | 2011 | 5655 | 0.070 |
Why?
|
Cost of Illness | 1 | 2016 | 1852 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13921 | 0.070 |
Why?
|
Patient Discharge | 1 | 2019 | 3300 | 0.070 |
Why?
|
Mutation | 3 | 2021 | 29717 | 0.070 |
Why?
|
Risk Assessment | 2 | 2017 | 23320 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6294 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3111 | 0.060 |
Why?
|
Genomics | 4 | 2021 | 5692 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2012 | 1130 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3456 | 0.060 |
Why?
|
Colonoscopy | 1 | 2012 | 1365 | 0.060 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2012 | 987 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2011 | 1740 | 0.060 |
Why?
|
Mice, Inbred C57BL | 4 | 2015 | 21821 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15530 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5425 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4823 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 24913 | 0.050 |
Why?
|
Poly(A)-Binding Protein I | 1 | 2021 | 14 | 0.050 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2012 | 1384 | 0.050 |
Why?
|
Lysine | 1 | 2006 | 1008 | 0.050 |
Why?
|
Glutamic Acid | 1 | 2006 | 1167 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2021 | 11363 | 0.050 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2012 | 1728 | 0.050 |
Why?
|
Prevalence | 1 | 2017 | 15194 | 0.050 |
Why?
|
Exons | 1 | 2006 | 2431 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19862 | 0.040 |
Why?
|
Polyesters | 2 | 2012 | 363 | 0.040 |
Why?
|
Incidence | 1 | 2018 | 20928 | 0.040 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2020 | 91 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 13853 | 0.040 |
Why?
|
Mice | 6 | 2015 | 81045 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2006 | 4187 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2017 | 25575 | 0.040 |
Why?
|
Phthalazines | 1 | 2019 | 361 | 0.040 |
Why?
|
Microsatellite Instability | 1 | 2020 | 678 | 0.040 |
Why?
|
Lactic Acid | 2 | 2012 | 1132 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13655 | 0.030 |
Why?
|
Mice, SCID | 2 | 2012 | 2715 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 29010 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 2020 | 477 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1062 | 0.030 |
Why?
|
Polymers | 2 | 2012 | 1618 | 0.030 |
Why?
|
Adolescent | 2 | 2016 | 85649 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2020 | 1780 | 0.030 |
Why?
|
Animals | 6 | 2015 | 168561 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 21596 | 0.030 |
Why?
|
Bone Marrow Transplantation | 2 | 2011 | 2763 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9185 | 0.030 |
Why?
|
Intestinal Polyps | 1 | 2012 | 99 | 0.030 |
Why?
|
United States | 1 | 2019 | 69693 | 0.020 |
Why?
|
Transplantation, Isogeneic | 1 | 2011 | 257 | 0.020 |
Why?
|
Cell Survival | 2 | 2011 | 5872 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2021 | 2266 | 0.020 |
Why?
|
Y Chromosome | 1 | 2012 | 206 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2012 | 276 | 0.020 |
Why?
|
Elastin | 1 | 2011 | 305 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2723 | 0.020 |
Why?
|
Magnetite Nanoparticles | 1 | 2011 | 322 | 0.020 |
Why?
|
Matrix Metalloproteinases | 1 | 2011 | 391 | 0.020 |
Why?
|
Piperazines | 1 | 2019 | 2488 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2011 | 9735 | 0.020 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 2011 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3585 | 0.020 |
Why?
|
Cell Line | 2 | 2012 | 15994 | 0.020 |
Why?
|
Bioprosthesis | 1 | 2011 | 596 | 0.020 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2010 | 686 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2012 | 2638 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2012 | 2110 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2011 | 1835 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2011 | 1350 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 2513 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16331 | 0.010 |
Why?
|
Collagen | 1 | 2011 | 2684 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2010 | 1670 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 213127 | 0.010 |
Why?
|
Adult | 3 | 2021 | 213712 | 0.010 |
Why?
|
Aged | 3 | 2021 | 162944 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17400 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 5978 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2010 | 3455 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 40450 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 57683 | 0.010 |
Why?
|
Apoptosis | 1 | 2012 | 9715 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11470 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9581 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 40054 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 35342 | 0.000 |
Why?
|